MedPath

Thomson VisiPro Capsule

Registration Number: MAL22066091N

Approved
Approval ID

af2856e21ec526c8

Registration Number

MAL22066091N

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (3)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (3)

TAGETES ERECTA (MARIGOLD) EXTRACTActive
Monograph: tagetes erecta (marigold) extract
GINKGO BILOBA LEAF EXTRACTActive
Monograph: ginkgo biloba leaf extract
HAEMATOCOCCUS PLUVIALIS EXTRACTActive
Monograph: haematococcus pluvialis extract

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Thomson VisiPro Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform